Incidence and predictors of interstitial lung disease (ILD) in Thai patients with early systemic sclerosis: Inception cohort study

被引:38
|
作者
Wangkaew, Suparaporn [1 ]
Euathrongchit, Juntima [2 ]
Wattanawittawas, Pittaporn [1 ]
Kasitanon, Nuntana [1 ]
Louthrenoo, Worawit [1 ]
机构
[1] Chiang Mai Univ, Dept Internal Med, Div Rheumatol, Chiang Mai 50000, Thailand
[2] Chiang Mai Univ, Fac Med, Div Diagnost Radiol, Chiang Mai 50000, Thailand
关键词
HRCT; Incidence; Interstitial lung disease; Predictors; Systemic sclerosis; RESOLUTION COMPUTED-TOMOGRAPHY; IDIOPATHIC PULMONARY-FIBROSIS; CT; HYPERTENSION; SURVIVAL; CHEST;
D O I
10.3109/14397595.2015.1115455
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: To determine and compare the prevalence of interstitial lung disease (ILD), the severity of high-resolution computed tomography (HRCT) score and incidence rate (IR) of ILD between the two subsets of early-SSc (systemic sclerosis) patients. We also determined the factors associated with ILD.Methods: We used an inception cohort of early-SSc patients seen between January 2010 and June 2014. All patients underwent HRCT at study entry and annually thereafter.Results: One hundred and thirteen patients (66 females and 89 diffuse cutaneous SSc [dcSSc]) with a meanSD age of 53.4 +/- 8.4 years and mean disease duration of 12.9 +/- 10.3 months at cohort entry were enrolled. At enrollment, patients with dcSSc had a higher prevalence of ILD (78.7% vs. 45.8%, p=0.002), and a higher total HRCT score (10.3 +/- 9.5 vs. 4.4 +/- 5.6, p=0.001) compared with limited cutaneous SSc (lcSSc). DcSSc patients had a higher IR of ILD than lcSSc patients (58.8 vs.17.3 per 100 person-years, p<0.001). Univariable analysis revealed that male gender, presence of anti-Scl 70 and absent anti-centromere antibody was significant predictors of ILD. In Cox-regression analysis, a positive anti-centromere [hazard ratio (HR) 0.09 95% confidence interval (95% CI 0.01-0.73)] was a protective factor.Conclusions: DcSSc patients had more severe HRCT scores and higher IR of ILD compared with lcSSc patients. Male gender, presence of anti-Scl 70, and absent anti-centromere antibody predicted the future development of ILD in early-SSc patients.
引用
收藏
页码:588 / 593
页数:6
相关论文
共 50 条
  • [21] Clinical Predictors of Lung-Function Decline in Systemic-Sclerosis-Associated Interstitial Lung Disease Patients with Normal Spirometry
    Nagy, Tamas
    Toth, Nora Melinda
    Palmer, Erik
    Polivka, Lorinc
    Csoma, Balazs
    Nagy, Alexandra
    Eszes, Noemi
    Vincze, Krisztina
    Barczi, Eniko
    Bohacs, Aniko
    Tarnoki, Adam Domonkos
    Tarnoki, David Laszlo
    Nagy, Gyorgy
    Kiss, Emese
    Maurovich-Horvat, Pal
    Muller, Veronika
    BIOMEDICINES, 2022, 10 (09)
  • [22] Prediction of progressive fibrosing interstitial lung disease in patients with systemic sclerosis: insight from the CRDC cohort study
    Hui, Min
    Duan, Xinwang
    Zhou, Jiaxin
    Li, Mengtao
    Wang, Qian
    Zhao, Jiuliang
    Hou, Yong
    Xu, Dong
    Zeng, Xiaofeng
    RMD OPEN, 2024, 10 (01):
  • [23] Treatment and Systemic Sclerosis Interstitial Lung Disease Outcome: The Overweight Paradox
    Nagy, Alexandra
    Palmer, Erik
    Polivka, Lorinc
    Eszes, Noemi
    Vincze, Krisztina
    Barczi, Eniko
    Bohacs, Aniko
    Tarnoki, Adam Domonkos
    Tarnoki, David Laszlo
    Nagy, Gyoergy
    Kiss, Emese
    Maurovich-Horvat, Pal
    Mueller, Veronika
    BIOMEDICINES, 2022, 10 (02)
  • [24] Predictors and prognosis of pulmonary hypertension complicating interstitial lung disease in systemic sclerosis
    Morrisroe, Kathleen
    Hansen, Dylan
    Stevens, Wendy
    Ross, Laura
    Sahhar, Joanne
    Ngian, Gene-Siew
    Hill, Catherine
    Host, Lauren
    Walker, Jennifer
    Proudman, Susanna
    Nikpour, Mandana
    RHEUMATOLOGY, 2024,
  • [25] Interstitial lung disease in systemic sclerosis: progress in screening and early diagnosis
    Molberg, Oyvind
    Hoffmann-Vold, Anna-Maria
    CURRENT OPINION IN RHEUMATOLOGY, 2016, 28 (06) : 613 - 618
  • [26] Tracking Impact of Interstitial Lung Disease in Systemic Sclerosis in a Complete Nationwide Cohort
    Hoffmann-Vold, Anna-Maria
    Fretheim, Havard
    Halse, Anne-Kristine
    Seip, Marit
    Bitter, Helle
    Wallenius, Marianne
    Garen, Torhild
    Salberg, Anne
    Brunborg, Cathrine
    Midtvedt, Oyvind
    Lund, May Brit
    Aalokken, Trond M.
    Molberg, Oyvind
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 200 (10) : 1258 - 1266
  • [27] High Prevalence of Acute Exacerbation of Interstitial Lung Disease in Japanese Patients with Systemic Sclerosis
    Tomiyama, Fumiko
    Watanabe, Ryu
    Ishii, Tomonori
    Kamogawa, Yukiko
    Fujita, Yoko
    Shirota, Yuko
    Sugimura, Koichiro
    Fujii, Hiroshi
    Harigae, Hideo
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2016, 239 (04) : 297 - 305
  • [28] Tomographic Fibrosis Score in the Patients with Systemic Sclerosis-Associated Interstitial Lung Disease
    Ozmen, Mustafa
    Gumus, Cesur
    Otman, Eda
    Sinci, Kazim Ayberk
    Aysin, Idil Kurut
    Solmaz, Dilek
    Akar, Servet
    EUROPEAN JOURNAL OF RHEUMATOLOGY, 2023, 10 (03) : 107 - 113
  • [29] Systemic Sclerosis Associated Interstitial Lung Disease: A Comprehensive Overview
    Mackintosh, John A.
    Stainer, Anna
    Barnett, Joseph L.
    Renzoni, Elisabetta A.
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 40 (02) : 208 - 226
  • [30] Management of systemic sclerosis-associated interstitial lung disease
    Roofeh, David
    Jaafar, Sara
    Vummidi, Dharshan
    Khanna, Dinesh
    CURRENT OPINION IN RHEUMATOLOGY, 2019, 31 (03) : 241 - 249